Zimmer Biomet Holdings, INC Form 4 insider transactions

Zimmer Biomet Holdings, Inc. Director Sreelakshmi Kolli acquired 171.496 phantom stock units as part of a deferred compensation plan, increasing her beneficial ownership to 5,221.199 units.

Zimmer Biomet Holdings, Inc. Director Devdatt Kurdikar has accrued an additional 150.916 phantom stock units under the company's deferred compensation plan, increasing his total beneficial ownership to 1,470.296 units.

Sang Yi, Group President of Asia Pacific at Zimmer Biomet Holdings, Inc., reported the sale of 800 shares of company common stock for approximately $74,011.20.

Sang Yi, Group President of Asia Pacific at Zimmer Biomet Holdings, Inc., reported the sale of 1,000 shares of common stock for $95 per share.

Zimmer Biomet Holdings, Inc.'s VP, Controller & CAO, Paul A. Stellato, reported the vesting of restricted stock units and subsequent stock transactions, including shares withheld for tax obligations.

Zimmer Biomet Holdings, Inc. Director Michael J. Farrell reported the acquisition of 810.46 phantom stock units and 1,404.798 restricted stock units as part of his compensation.

Zimmer Biomet Holdings, Inc. Director Maria Teresa Hilado reported the acquisition of 810.46 phantom stock units and 1,404.798 restricted stock units on May 29, 2025, increasing her beneficial ownership in the company.

Zimmer Biomet Holdings, Inc. Director Devdatt Kurdikar acquired 810.46 phantom stock units and 1,404.798 restricted stock units on May 29, 2025, aligning his interests with shareholders.

Zimmer Biomet Holdings, Inc. Director Sreelakshmi Kolli acquired 810.46 phantom stock units and 1,404.798 restricted stock units on May 29, 2025, as part of the company's deferred compensation and equity plans.

Zimmer Biomet Holdings, Inc. Director Syed A. Jafry increased his beneficial ownership by acquiring additional phantom stock units and restricted stock units on May 29, 2025.

Zimmer Biomet Holdings, Inc. Director Arthur J. Higgins reported the acquisition of phantom stock units and restricted stock units as part of his compensation on May 29, 2025.

Zimmer Biomet Holdings, Inc. Director Robert Hagemann reported the acquisition of 810.46 phantom stock units and 1,404.798 restricted stock units on May 29, 2025, as part of his compensation.

Betsy J. Bernard, a Director at Zimmer Biomet Holdings, Inc., acquired phantom stock units and restricted stock units on May 29, 2025, as part of her compensation.

Zimmer Biomet Holdings, Inc. Director Louis Shapiro reported the acquisition of 810.46 phantom stock units and 1,404.798 restricted stock units on May 29, 2025, as part of his compensation.

Jehanzeb Noor, a Senior Vice President at Zimmer Biomet, acquired 19,875 restricted stock units on April 1, 2025, according to a Form 4 filing.

Director Michael J. Farrell reports acquisition of phantom stock units in Zimmer Biomet Holdings, Inc. under deferred compensation plan.

Director Christopher B. Begley reports the acquisition of phantom stock units in Zimmer Biomet Holdings, Inc. through a deferred compensation plan.

Director Robert Hagemann reports acquiring phantom stock units in Zimmer Biomet Holdings, Inc. under the Deferred Compensation Plan for Non-Employee Directors.

Director Arthur J. Higgins reports acquiring phantom stock units in Zimmer Biomet Holdings, Inc. under the deferred compensation plan.

Director Maria Teresa Hilado reports acquiring phantom stock units in Zimmer Biomet Holdings, Inc. under the deferred compensation plan.

Director Kolli Sreelakshmi reports acquiring phantom stock units in Zimmer Biomet Holdings, Inc. under the company's deferred compensation plan.

Director Louis Shapiro reports acquiring phantom stock units in Zimmer Biomet Holdings, Inc. through a deferred compensation plan.

Director Devdatt Kurdikar reports acquisition of phantom stock units in Zimmer Biomet Holdings, Inc. under the Deferred Compensation Plan for Non-Employee Directors.

Chad F. Phipps, a Senior VP/General Counsel/Secretary at Zimmer Biomet Holdings, Inc., reported the vesting of restricted stock units and subsequent tax withholding, resulting in changes to his beneficial ownership of company stock.

Mark Bezjak, President, Americas at Zimmer Biomet Holdings, Inc., reports the vesting and disposal of restricted stock units to cover tax obligations.

Paul A. Stellato, VP, Controller & CAO of Zimmer Biomet Holdings, Inc., reports the vesting of restricted stock units and subsequent tax withholding.

Lori Winkler, SVP and CHRO of Zimmer Biomet Holdings, Inc., reports the acquisition and disposal of company stock and restricted stock units.

Wilfred van Zuilen, Group President EMEA at Zimmer Biomet, reports the vesting of restricted stock units and subsequent stock transactions on March 6, 2025.

Zimmer Biomet's President & CEO, Ivan Tornos, reports the vesting of restricted stock units and subsequent stock transactions to cover tax obligations.

Suketu Upadhyay, CFO of Zimmer Biomet Holdings, Inc., reports the vesting of restricted stock units and subsequent tax withholding, resulting in changes to his beneficial ownership of company stock.